264 related articles for article (PubMed ID: 25355178)
1. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.
Beesley VL; Smithers BM; Khosrotehrani K; Khatun M; O'Rourke P; Hughes MC; Malt MK; Zonta MJ; Bayley GJ; Barbour AP; Brown LJ; D'Arcy J; Allan CP; Green AC
Psychooncology; 2015 Jul; 24(7):763-70. PubMed ID: 25355178
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma.
Molassiotis A; Brunton L; Hodgetts J; Green AC; Beesley VL; Mulatero C; Newton-Bishop JA; Lorigan P
Ann Oncol; 2014 Oct; 25(10):2052-2058. PubMed ID: 25081900
[TBL] [Abstract][Full Text] [Related]
3. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.
Beesley VL; Smithers BM; O'Rourke P; Janda M; Khosrotehrani K; Green AC
Support Care Cancer; 2017 Jan; 25(1):93-102. PubMed ID: 27562298
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
6. Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about?
Körner A; Garland R; Czajkowska Z; Coroiu A; Khanna M
Eur J Oncol Nurs; 2016 Feb; 20():150-5. PubMed ID: 26236032
[TBL] [Abstract][Full Text] [Related]
7. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia.
Smithers BM; Hughes MC; Beesley VL; Barbour AP; Malt MK; Weedon D; Zonta MJ; Wood DJ; Triscott JA; Bayley GJ; Brown LJ; Allan CP; D'Arcy J; Williamson R; Khosrotehrani K; Green AC
J Surg Oncol; 2015 Sep; 112(4):359-65. PubMed ID: 26310597
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
10. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
11. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results.
Henry M; Habib LA; Morrison M; Yang JW; Li XJ; Lin S; Zeitouni A; Payne R; MacDonald C; Mlynarek A; Kost K; Black M; Hier M
Palliat Support Care; 2014 Dec; 12(6):481-93. PubMed ID: 24153040
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial benefits of sentinel lymph node biopsy in the management of cutaneous malignant melanoma.
Rayatt SS; Hettiaratchy SP; Key A; Powell BW
Br J Plast Surg; 2002 Mar; 55(2):95-9. PubMed ID: 11987939
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the use of sentinel lymph node biopsy in the Netherlands.
Huismans AM; Niebling MG; Wevers KP; Schuurman MS; Hoekstra HJ
Ann Surg Oncol; 2014 Oct; 21(11):3395-400. PubMed ID: 24819123
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
17. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
[TBL] [Abstract][Full Text] [Related]
18. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
[TBL] [Abstract][Full Text] [Related]
19. Changes in supportive care needs after first-line treatment for ovarian cancer: identifying care priorities and risk factors for future unmet needs.
Beesley VL; Price MA; Webb PM; O'Rourke P; Marquart L; ; ; Butow PN
Psychooncology; 2013 Jul; 22(7):1565-71. PubMed ID: 22936668
[TBL] [Abstract][Full Text] [Related]
20. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
